Results 21 to 30 of about 196,277 (209)

Pathophysiology of elevated ascites fluid cholesterol in malignant ascites [PDF]

open access: yes, 1992
The existence of marked elevations of ascitic fluid cholesterol has been observed in patients with peritoneal carcinomatosis compared to patients with cirrhosis and has been found useful in differential diagnosis.
Jüngst, Dieter   +2 more
core   +1 more source

Medical treatment of ascites in cirrhosis [PDF]

open access: yes, 1993
Medical treatment of cirrhotic ascites is essentially supportive, dictated by the patient's discomfort, impaired cardiovascular or respiratory function and potential for infection. Treatment of ‘simple’ ascites (moderate fluid accumulation, serum albumin
Gerbes, Alexander L.
core   +1 more source

Refractory Ascites [PDF]

open access: yesDigestive Diseases, 2005
Patients with cirrhosis have significant abnormalities in their fluid and electrolyte balance; this is manifested mainly by the development of ascites and edema. Ascites is the most common complication of patients with cirrhosis and its development constitutes the first and most important manifestation of the disease. With disease progression, patients
Andrés, Cárdenas, Vicente, Arroyo
openaire   +2 more sources

Level of MFAP4 in ascites independently predicts 1-year transplant-free survival in patients with cirrhosis

open access: yesJHEP Reports, 2021
Background & Aims: Prognostic models of cirrhosis underestimate disease severity for patients with cirrhosis and ascites. Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix protein linked to hepatic neoangiogenesis and ...
Nikolaj Torp   +13 more
doaj   +1 more source

Myxoedema ascites [PDF]

open access: yesPostgraduate Medical Journal, 1977
Summary A case of myxoedema ascites complicating ischaemic heart disease is reported. Partial thyroid hormone replacement therapy, given slowly, eventually produced a diuresis and complete resolution of the ascites after a delay of 4 weeks.
J A, Turner, J, Rapoport
openaire   +2 more sources

Improved quality of life in patients with refractory or recidivant ascites after insertion of transjugular intrahepatic portosystemic shunts [PDF]

open access: yes, 2002
Background. We have recently shown that the transjugular intrahepatic portosystemic shunt (TIPS) is more effective than paracentesis in the treatment of cirrhotic patients with severe ascites and can prolong survival in selected patients.
Reiser, Maximilian F.   +5 more
core   +1 more source

Current management of refractory ascites in patients with cirrhosis

open access: yesJournal of International Medical Research, 2018
Liver cirrhosis is a health problem worldwide, and ascites is its principal symptom. Refractory ascites is intractable and occurs in 5%–10% of all patients with ascites due to cirrhosis.
Ruihong Zhao   +5 more
doaj   +1 more source

A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites

open access: yesBMC Cancer, 2018
Background Ramucirumab has recently proved to be effective for advanced or recurrent gastric cancer (AGC). Ascites and peritoneal metastasis are among the most common complications of AGC.
Hiroshi Matsumoto   +10 more
doaj   +1 more source

Prognostic value of ascites in patients with liver cirrhosis undergoing cardiac surgery

open access: yesJournal of Cardiothoracic Surgery, 2023
Introduction Mild or moderate liver cirrhosis increases the risk of complications after cardiac surgery. Ascites is the most common complication associated with liver cirrhosis.
Amila Cizmic   +5 more
doaj   +1 more source

Value of Ascitic Lipids in the Differentiation between Cirrhotic and Malignant Ascites [PDF]

open access: yes, 1986
Ascitic fluid concentrations of cholesterol, triglycerides and phospholipids, were compared with ascitic fluid total protein in 40 patients with chronic liver disease, 51patients with various neoplasms and 1 patient with cardiac failure.
Martin, Robert   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy